Company Overview
- Headquarters
- 343 Allerton Avenue, South San Francisco CA
- Website
- vistagen.com
- Phone
- (650) 577-3600
- Employees
- 45
- Industry
- Materials/Manufacturing
- Stock Symbol
- NASDAQ:VTG
Financials & Stats
Revenue
$10B
Who is Vistagen
Vistagen is a late clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company employs 45 people and operates within the United States. Vistagen focuses on developing innovative therapies for psychiatric and neurological disorders. Their product pipeline consists of six clinical-stage candidates, five of which are investigational neuroactive nasal sprays called pherines. These pherines are designed to activate chemosensory neurons in the nasal passages, impacting brain circuits without systemic absorption or receptor binding. Their sixth candidate, AV-101, is an oral drug aimed at inhibiting NMDA receptor activity. What sets Vistagen apart is their focus on developing pherines, a novel class of drugs with the potential for rapid efficacy and a differentiated safety profile. This approach seeks to address the unmet needs in treating anxiety, depression, and other neurological disorders. Vistagen can be contacted through their website at vistagen.com.
Company Leadership
Vistagen Industry Tags
Companies Similar to Vistagen
Analyze industry trends and opportunities by examining competitors and companies comparable to Vistagen, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
10M | 30 | Newtown, PA | 1998 | |
10M | 10 | Redwood City, CA | ||
10M | 8 | Houston, TX | 2011 | |
10M | 16 | Bethlehem, PA | 2005 | |
10M | Pittsburgh, PA |